BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3988211)

  • 1. [Is hemorheologic therapy in cerebrovascular disorders ready for general practice].
    Ernst E
    Fortschr Med; 1985 Feb; 103(6):107-8. PubMed ID: 3988211
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy from the hemorheologic viewpoint. 1: Hemodilution and defibrinogenation].
    Ernst E
    Fortschr Med; 1986 Jun; 104(21):423-6. PubMed ID: 3732982
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemorheologic treatment of acute cerebrovascular disorders: what is safe?].
    Thie A; Kunze K; Spitzer K
    Med Klin (Munich); 1988 Mar; 83(5):178-82. PubMed ID: 3287115
    [No Abstract]   [Full Text] [Related]  

  • 4. Rheology and strokes.
    Thomas DJ
    Curr Opin Neurol Neurosurg; 1992 Feb; 5(1):44-8. PubMed ID: 1623237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemorrheological changes in cerebrovascular disease].
    Fieschi C; Iadecola C
    Ric Clin Lab; 1983; 13 Suppl 3():189-93. PubMed ID: 6672995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodilution therapy of cerebrovascular diseases].
    Yamamoto M; Shinohara Y
    No To Shinkei; 1992 Sep; 44(9):787-95. PubMed ID: 1282355
    [No Abstract]   [Full Text] [Related]  

  • 7. [Microcirculatory, hemorheologic and microcirculatory parameters before and following hypervolemic hemodilution in patients with acute cerebrovascular disorders].
    Staedt U; Kortsik C; Seufzer U; Lessenich A; Hütt M; Keller H
    Vasa Suppl; 1989; 27():33-4. PubMed ID: 2482989
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
    Walzl B; Walzl M; Lechner P; Lechner H; Cesnik H
    Wien Med Wochenschr; 1993; 143(22):563-70. PubMed ID: 8154130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemical, rheological and clinical aspects of using the HELP system in the treatment of hypercholesterolemia and cerebrovascular disorders].
    Kowal P
    Neurol Neurochir Pol; 1992; 26(4):538-44. PubMed ID: 1484581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic consequences of hemorheologic research].
    Ernst E
    Wien Med Wochenschr; 1989 Dec; 139(24):569-80. PubMed ID: 2696217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
    Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K
    Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline.
    Ott E; Lechner H
    Ric Clin Lab; 1981; 11 Suppl 1():253-6. PubMed ID: 7188113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathophysiologic basis and clinical use of hemodilution in the treatment of cerebrovascular circulation disorders].
    Lopacz-Stoczek S
    Wiad Lek; 1986 Sep; 39(17):1181-6. PubMed ID: 3548078
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodilution in acute ischemic insults. Comparative study on the clinical and hemorheologic effectiveness of 10% HES 200/0.5 and 10% dextran 40].
    Schneider R; Hacke W; Kiesewetter H; Jung F
    Fortschr Med; 1985 Nov; 103(44):1031-4. PubMed ID: 2416658
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemorheologic therapy. Status and perspectives].
    Haass A
    Nervenarzt; 1989 Sep; 60(9):528-39. PubMed ID: 2682298
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lisinopril effects on cerebral blood flow and blood rheology in hypertensive patients].
    Markova LI; Kuznetsova IV; Radzevich AE
    Ter Arkh; 2004; 76(11):41-3. PubMed ID: 15658536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy with hemorheologic considerations. 2: Rheologic agents].
    Ernst E
    Fortschr Med; 1987 Feb; 105(4):69-72. PubMed ID: 3557263
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations on isovolemic hemodilution in acute ischemic stroke.
    Comes L; Mureşan A; Costin Z
    Rom J Intern Med; 1996; 34(1-2):43-7. PubMed ID: 8908629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nisoldipine on red cell deformability and platelet aggregation in stroke patients.
    Kuzuya F; Hayakawa M
    Arzneimittelforschung; 1994 Nov; 44(11):1214-6. PubMed ID: 7848334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.